Product Images Tobramycin Inhalation Solution

This graph shows the average relative change in FEV1% predicted for two different studies involving tobramycin inhalation solution and a placebo. The first study had 109 participants on the drug and 114 on the placebo, and the second study had 149 on the drug and 148 on the placebo. The graph is plotted over a period of 24 weeks, with the number of participants at baseline indicated by the asterisk.*

This is a description of Tobramycin Inhalation Solution, USP which is a medication that is kept in a refrigerator. It is suitable for inhalation only by nebulizer and consists of 56 single-dose 5mL ampules that can be used for a 28-day supply. The package contains four single-dose 5 mL ampules per pouch, with 14 pouches per carton. The medication is sterile and does not contain any preservatives. The text also includes some product codes and location information, but these are peripheral to the main description.*

This is a list of items that is not useful on its own without additional context. Therefore, it is not possible to provide a meaningful description.*

This appears to be a description of a nebulizer and its various components. It lists the outlet, mouthpiece, and nebulizer cup. A nebulizer is a medical device that converts liquid medicine into a mist that can be inhaled through a mask or mouthpiece. It is commonly used to treat respiratory conditions such as asthma, COPD, and cystic fibrosis.*

This is a medication in a foil pouch comprising four sterile single-dose ampoules, each containing 5mL of sterile water, 300mg of Tobramycin USP, and 11.25mg of sodium chloride. The medication is intended for inhalation only and must be administered through a nebulizer to deliver a single 300mg dose. Users need to read the package insert before prescribing, and store the medicine at a temperature of 2° to 8°C. It does not contain preservatives and is verified by Holopack Verpackungstechnik GmbH at their address in Germany. The product has an NDC number of 16714-118:02.*